ArticleCEN case reports2022

Complete remission of tip lesion variant focal segmental glomerulosclerosis (FSGS) with the Janus Kinase (JAK) inhibitor tofacitinib.

Martin Sedlacek et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.